Back to Search
ARI POLLACK, MD
MD
Pediatric Nephrology Physician
NPI: 1821087404IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Nephrology PhysicianPrimary
Pediatrics — Pediatric Nephrology
Code: 2080P0210X
MD00045371(WA)
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
Development and order set utilization in ambulatory pediatric specialty care.
PMID 18694176·AMIA Annu Symp Proc·2007
8-other
Analysis of targeted mutation in DJ-1 on cellular function in primary astrocytes.
PMID 19063952·Toxicol Lett·2009
7-preclinical
Early OCT changes of neuroretinal foveal thickness after first versus repeated PDT in AMD.
PMID 18094940·Int Ophthalmol·2009
4-observational
Developing a radiation error scoring system to monitor quality control events in a radiation oncology department.
PMID 19111271·J Am Coll Radiol·2009
8-other
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
PMID 18977097·Int J Radiat Oncol Biol Phys·2009
8-other
Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.
PMID 19598213·Laryngoscope·2009
5-case
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
PMID 19470936·J Clin Oncol·2009
2-rct
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
PMID 19464826·Int J Radiat Oncol Biol Phys·2009
8-other
Predictive models in external beam radiotherapy for clinically localized prostate cancer.
PMID 19544539·Cancer·2009
6-review
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
PMID 19386445·Int J Radiat Oncol Biol Phys·2009
6-review
Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.
PMID 19010821·Mol Cancer Res·2008
8-other
Long-term follow up of antenatally diagnosed megaureters.
PMID 18631923·J Pediatr Urol·2008
4-observational
Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: the moderating role of age.
PMID 18350459·Psychol Health Med·2008
8-other
Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg.
PMID 18536598·Retina·2008
4-observational
Behavioral disorders in children with idiopathic intracranial hypertension.
PMID 18401035·J Child Neurol·2008
3-trial
Does treatment duration affect outcome after radiotherapy for prostate cancer?
PMID 18472368·Int J Radiat Oncol Biol Phys·2008
8-other
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.
PMID 18455330·Int J Radiat Oncol Biol Phys·2008
3-trial
Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
PMID 18852870·Mol Vis·2008
8-other
Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel.
PMID 19065273·Mol Vis·2008
8-other
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
PMID 18672274·Urology·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4800 SAND POINT WAY NE # OC.9820
SEATTLE, WA 98105 - Phone
- (206) 987-2524
Quick Facts
- NPI
- 1821087404
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile